Hubbell Incorporated vs Xylem
Xylem is the larger business, with $9.04bn of revenue in fiscal 2025 against $5.84bn for Hubbell Incorporated (1.5 times as much). Xylem grew faster (5.5% against 3.8%). Hubbell Incorporated kept more of each dollar of sales as profit: a net margin of 15.2% against 10.6%.
| Latest fiscal year | Hubbell IncorporatedHUBB, 2025 | XylemXYL, 2025 |
|---|---|---|
| Revenue | $5.84bn | $9.04bn |
| Revenue growth | 3.8% | 5.5% |
| Net income | $887m | $957m |
| Operating margin | — | 13.5% |
| Net margin | 15.2% | 10.6% |
| Return on equity | 24.5% | 8.7% |
| Free cash flow | $875m | $910m |
| Cash | $483m | $1.48bn |
| Total debt | $2.33bn | $2.49bn |
| Debt to equity | — | 21.7% |
| Dividend per share | — | $1.60 |
| Dividend yield | — | 1.8% |
| Share buybacks | $225m | $15.0m |
| Employees | — | 22,000 |
| Market value | $23.74bn | $22.36bn |
| Price vs our value range | Within our value range | Above our value range |
| Moat score | 74 (Strong) | 63 (Moderate) |
| Insider trades, 12 months | 1 buys, 19 sales | 2 buys, 2 sales |